Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
Dr. Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono International in Geneva, Switzerland will present at the Plenary Keynote session at GTCbio's 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA.

/Biotechnology News Articles/ - MONROVIA, CA, August 23, 2008 - Dr. Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono International in Geneva, Switzerland will present at the Plenary Keynote session at GTCbio's 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA.

Dr. Luthman's presentation entitled "Small Pharma, Big Pharma and Small Drugs and Big Drugs; Or Middle Way for Mid-Pharma?" will cover the advancements thus far in the field of drug discovery and development in relation to different pharmaceutical companies. He will address major challenges in traditional R&D organizational models and processes and the overall strategies of pharmaceutical companies. Dr. Luthman will also discuss the options for small, start up, companies as well as the advantages and disadvantages of Mid-sized pharmaceutical companies.

The 4th Modern Drug Discovery & Development Summit features over 150 speakers participating in 6 concurrent conferences, 6 mini sessions and 3 short symposia. Other plenary speakers include John Doll, Commissioner of Patents at the US Patent & Trademark Office, David Nicholson, SVP of Global Project Management at Schering Plough, Keith James, SVP & Site Head at Pfizer La Jolla, Ashraf Hanna, Vice President of Alliance Management and Portfolio Planning at Genentech and Sandy Macrae, VP of Business Development at GlaxoSmithKline. The 6 tracks will cover Biological Therapeutics, Translational Medicine, Drug Design & Lead Optimization, Emerging Targets &, Pharmacokinetics & Pharmacodynamics and Partnering, Licensing & Outsourcing. For more information, visit www.gtcbio.com.


Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com

Press Release Contact Information:

Rania Hafez
GTCbio
Marketing Director
434 W. Foothill Blvd.
Monrovia, CA
USA 91106
Voice: 626-256-6405
Fax: 626-256-6460
Website: Visit Our Website